Summaries & Associations of Study Results
TR-105 m-Cresidine
Target Organs and Levels of Evidence
NTP Technical Report Number 105
Produced from Chemtrack Database 09/19/01
CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
---|---|---|---|---|
M-CRESIDINE 102-50-1 |
03/06/78 | DYE INTERMEDIATE | Gavage R: 0,.08,.16, M: 0,.06,.11 (AVG) G/KG/50 PER GROUP | T.S.I. Mason Laboratories, Inc. |
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
MR: POSITIVE | URINARY BLADDER (TRANSITIONAL CELL CARCINOMA) | |||
FR: POSITIVE | URINARY BLADDER (TRANSITIONAL CELL CARCINOMA) | |||
MM: INADEQUATE STUDY | ||||
FM: NEGATIVE |
Web page last updated on February 10, 2006